Aehr Test Systems

Fundamentals6.0
Price Action6.0
News Sentiment7.0
AI Rating
6.0

Key Drivers

  • High cash buffer
  • Falling margins
  • Excess inventory

AI
AI Summary

6.0

AEHR has become a binary, order‑driven recovery: recent multi‑million production wins create a credible path to multi‑tens‑of‑millions revenue and consumables‑led margin recovery, but the investment outcome now depends entirely on timely conversion of a few hyperscaler/silicon‑photonics ramps and avoiding inventory write‑downs or customer delays.

AIDemand
ExecutionRisk
Concentration‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

6.0

Key Financial Insights:

  • High cash buffer
  • Falling margins
  • Excess inventory

AEHR is cash-rich and very low‑levered, providing a solid balance‑sheet buffer, but worsening gross and net margins, negative operating cash flow, and outsized inventory vs sales create near‑term solvency and valuation risk.

Liquidity
Risk

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Below SMA
  • Resistance zone
  • Short-term floor

AEHR shows short-term bearish momentum as price sits ~11% below its last month 21-day SMA with resistance near $41–$44 and a short-term floor around $33–$35.

Bearish
Support Level: $33–$35
Resistance Level: $41–$44

Sharp drop from $42.45 on 2026-03-11 to $34.52 on 2026-03-20, signaling short-term distribution and elevated volatility

Sentiment & News

7.0

Key News Insights:

  • Large AI orders
  • Rapid share rally
  • Mixed analyst sentiment

Aehr Test Systems has won significant AI- and silicon‑photonics wafer‑level burn‑in orders since Jan 2026, fueling a >100% YTD stock surge and sharp volatility amid mixed analyst views.

Semiconductor

Continued AI-driven order flow should sustain revenue momentum and volatility, making the stock sensitive to further contract announcements and analyst revisions